Human monoclonal single-chain antibodies specific to dengue virus envelope protein

Letters in Applied Microbiology

Volumn 58, Issue 3, 2014, Pages 270-277

  Saokaew, N ^a   Poungpair, O ^a   Panya, A ^a   Tarasuk, M ^a   Sawasdee, N ^a   Limjindaporn, T ^a   Chaicumpa, W ^a   Yenchitsomanus, P ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Dengue virus; Envelope protein; Human single chain variable fragments; Monoclonal antibody; Phage display; Virus entry

Indexed keywords

CHAINS; EPITOPES; MOLECULES; RECOMBINANT PROTEINS; VIRUSES;

DENGUE VIRUS; ENVELOPE PROTEINS; HUMAN ANTIBODIES; HUMAN SINGLE-CHAIN VARIABLE FRAGMENT; PHAGE-DISPLAY; SINGLE-CHAIN ANTIBODIES; SINGLE-CHAIN VARIABLE FRAGMENTS; SINGLE-CHAIN VARIABLE FRAGMENTS (SCFV); VIRUS ENTRY; VIRUS INFECTION;

MONOCLONAL ANTIBODIES;

HUMAN SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANTIBODY; ANTIGEN; DENGUE FEVER; INFECTIVITY; INHIBITOR; MOLECULAR ANALYSIS; PROTEIN; RODENT; VIRUS;

AEDES ALBOPICTUS; ANTIBODY LIBRARY; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BIOPANNING; CONTROLLED STUDY; CROSS REACTION; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 4; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; IMMUNOFLUORESCENCE TEST; MOLECULAR DOCKING; NONHUMAN; PHAGE DISPLAY; RECOMBINANT PLASMID; SERODIAGNOSIS; VERO CELL; VIRUS CULTURE; VIRUS PARTICLE;

ARTHROPODA; DENGUE VIRUS;

DENGUE VIRUS; ENVELOPE PROTEIN; HUMAN SINGLE-CHAIN VARIABLE FRAGMENTS; MONOCLONAL ANTIBODY; PHAGE DISPLAY; VIRUS ENTRY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; DENGUE; DENGUE VIRUS; EPITOPE MAPPING; HUMANS; IMMUNIZATION, PASSIVE; MICE; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SINGLE-CHAIN ANTIBODIES; VERO CELLS; VIRAL ENVELOPE PROTEINS;

EID: 84893858637     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/lam.12186     Document Type: Article

References (23)

1. Abd-Jamil, J., Cheah, C.Y. and AbuBakar, S. (2008) Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites. Protein Eng Des Sel 21, 605-611.
2. Allison, S.L., Schalich, J., Stiasny, K., Mandl, C.W. and Heinz, F.X. (2001) Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol 75, 4268-4275.
3. Beigel, J.H., Nordstrom, J.L., Pillemer, S.R., Roncal, C., Goldwater, D.R., Li, H., Holland, P.C., Johnson, S. et al. (2010) Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus. Antimicrob Agents Chemother 54, 2431-2436.
4. Chang, K.J. (1997) Studies on the serological cross-reaction between dengue and Japanese encephalitis. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 30, 207-218.
5. Chen, Y., Maguire, T., Hileman, R.E., Fromm, J.R., Esko, J.D., Linhardt, R.J. and Marks, R.M. (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3, 866-871.
6. Chin, J.F., Chu, J.J. and Ng, M.L. (2007) The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry. Microbes Infect 9, 1-6.
7. Domanski, P.J., Patel, P.R., Bayer, A.S., Zhang, L., Hall, A.E., Syribeys, P.J., Gorovits, E.L., Bryant, D. et al. (2005) Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureus. Infect Immun 73, 5229-5232.
8. Gromowski, G.D. and Barrett, A.D. (2007) Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 30, 349-360.
9. Guzman, M.G., Halstead, S.B., Artsob, H., Buchy, P., Farrar, J., Gubler, D.J., Hunsperger, E., Kroeger, A. et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8, S7-S16.
10. Heijtink, R.A., van Nunen, A.B., van Bergen, P., Ostberg, L., Osterhaus, A.D. and de Man, R.A. (2001) Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexes. J Med Virol 64, 427-434.
11. Hung, S.L., Lee, P.L., Chen, H.W., Chen, L.K., Kao, C.L. and King, C.C. (1999) Analysis of the steps involved in Dengue virus entry into host cells. Virology 257, 156-167.
12. Kulkeaw, K., Sakolvaree, Y., Srimanote, P., Tongtawe, P., Maneewatch, S., Sookrung, N., Tungtrongchitr, A., Tapchaisri, P. et al. (2009) Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin. J Proteomics 72, 270-282.
13. Laskowski, R.A., Macarthur, M.W., Moss, D.S. and Thornton, J.M. (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 26, 283-290.
14. Lok, S.M., Kostyuchenko, V., Nybakken, G.E., Holdaway, H.A., Battisti, A.J., Sukupolvi-Petty, S., Sedlak, D., Fremont, D.H. et al. (2008) Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol 15, 312-317.
15. Martina, B.E., Koraka, P. and Osterhaus, A.D. (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22, 564-581.
16. Murrell, S., Wu, S.C. and Butler, M. (2011) Review of dengue virus and the development of a vaccine. Biotechnol Adv 29, 239-247.
17. Poungpair, O., Chaicumpa, W., Kulkeaw, K., Maneewatch, S., Thueng-in, K., Srimanote, P., Tongtawe, P., Songserm, T. et al. (2009) Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes. J Virol Methods 159, 105-111.
18. Poungpair, O., Pootong, A., Maneewatch, S., Srimanote, P., Tongtawe, P., Songserm, T., Tapchaisri, P. and Chaicumpa, W. (2010) A human single chain transbody specific to matrix protein (M1) interferes with the replication of influenza A virus. Bioconjug Chem 21, 1134-1141.
19. Stiasny, K., Brandler, S., Kossl, C. and Heinz, F.X. (2007) Probing the flavivirus membrane fusion mechanism by using monoclonal antibodies. J Virol 81, 11526-11531.
20. Sukupolvi-Petty, S., Austin, S.K., Purtha, W.E., Oliphant, T., Nybakken, G.E., Schlesinger, J.J., Roehrig, J.T., Gromowski, G.D. et al. (2007) Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol 81, 12816-12826.
21. Sukupolvi-Petty, S., Austin, S.K., Engle, M., Brien, J.D., Dowd, K.A., Williams, K.L., Johnson, S., Rico-Hesse, R. et al. (2010) Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol 84, 9227-9239.
22. Taylor, C.P., Tummala, S., Molrine, D., Davidson, L., Farrell, R.J., Lembo, A., Hibberd, P.L., Lowy, I. et al. (2008) Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A. Vaccine 26, 3404-3409.
23. Watterson, D., Kobe, B. and Young, P.R. (2012) Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding. J Gen Virol 93, 72-82.